In addition, clarification of how these genomic data fit in with the evolving picture of the molecular classification of GBM will be illuminating: for example, are alterations of ERRFI1 specifically identified in the subgroup of GBMs with downstream evidence of EGFR activation that lack EGFR amplification or mutation [3]? This evidence concerns the gene ERRFI1 and glioblastoma.